• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    W

    Wythenshawe Hospital,Manchester University NHS Foundation Trust

    EST. 1902
    2,475论文总数
    8.4万引用总数

    Wythenshawe Hospital is an acute general hospital in Wythenshawe, South Manchester. It is managed by the Manchester University NHS Foundation Trust.

    论文量&引用量时间轴

    机构学者

    论文(2475)

    年份
    起
    –
    止
    排序
    1Efficiency of Nitrous Oxide Mix Utilisation in NHS Trusts in England: a Pilot Study.
    Della Solichan, Alice Rowley, Cliff Shelton, Catherine El-Zerbi, Charlotte Hadley
    2026Anaesthesia(2026)引用:1
    引用
    AI阅读
    加入学术空间
    2Optical Coherence Tomography Versus Angiographic Guidance in True Unprotected Left Main Bifurcation Disease: an OCTOBER Substudy.
    Emil N Holck,Lene D Andreasen, Omeed Neghabat,Peep Laanmets, Lone J H Mogensen,James C Spratt,Johan Bennett, Slobodan Calic,Simon Walsh,Peter O'kane,James Cockburn, Loghman Henerah,

    BACKGROUND:Dedicated randomised studies on intravascular imaging guidance in unprotected left main coronary artery (LMCA) disease are lacking. AIMS:We aimed to investigate the clinical feasibility of optical coherence tomography (OCT) guidance in percutaneous coronary intervention (PCI) of true LMCA bifurcation lesions and to evaluate its prognostic impact compared with angiographic guidance. METHODS:Patients with true LMCA bifurcation lesions who were randomised to either OCT or angiographic guidance in the OCTOBER Trial were included. The feasibility of OCT guidance was assessed as the proportion of patients with successful and analysable OCT pullbacks before, during, and after stenting. Clinical outcomes between the two groups were compared based on the incidence of a composite of major adverse cardiac events (MACE), comprising cardiac death, any myocardial infarction, or target lesion revascularisation. RESULTS:In total, 227 patients were included (OCT: 111, angiography: 116). OCT guidance was successful, with 98% of cases having a pre-stenting pullback performed and 96% a final pullback, as per protocol. The proximal LMCA stent edge was analysable in 43% of patients, and in the remaining 57%, only 5% were limited by insufficient image quality. No statistically significant difference in MACE was observed between the two groups (OCT: 14.4% vs angiography: 18.4%, hazard ratio 0.78, 95% confidence interval: 0.39-1.51). CONCLUSIONS:OCT-guided PCI in true LMCA bifurcation lesions was clinically feasible, but visibility of the LMCA ostium was limited by short pullbacks, insufficient clearance, or guide catheter shadowing. OCT guidance was associated with a non-significant reduction in MACE, consistent with the effect estimate in the main trial.

    2026EuroIntervention journal of EuroPCR in collaboration with the Working Group on Interventional Cardi...(2026)引用:1
    引用
    AI阅读
    加入学术空间
    3O32 Endoscopic Ultrasound-Directed Transgastric Interventions. Real World Data from 9 Tertiary Centres in the UK
    Khalid Bashir, Khurum Hakeem, Eoin Keating,Terry Wong, David Simon, Grant Peddie, Madison Shan,Mohamed Elseragy, Aikaterini Mountaki, Fawad Khattak, Mohamed Korani, Colme Forde
    2026Oral Abstracts(2026)
    引用
    AI阅读
    加入学术空间
    4Evaluation of a Novel Needle for Tissue Sampling at Endoscopic Ultrasound: a UK Multicentre Study
    Khurum Hakeem, Muhammad Shah, Danujan Sriranganathan,Mohamed Elseragy, Siraj Farid, Evelyn Lim,Shiran Esmaily, Ramy ElHusseiny, Waqas Khan, Jennifer Campbell,Aaron McGowan
    2026GUT(2026)
    引用
    AI阅读
    加入学术空间
    5Protocol for Mesothelioma Observational Study of Risk Prediction and Generation of Paired Benign-Meso Tissue Samples, Including a Nested MRI Substudy (Meso-Origins)
    Mark D J Neilly,Alexandrea MacPherson,Laura Alexander,Nicola Walker,Caroline Kelly,Joshua Roche, Emad Abugassa, Liam Allan, Adeel Ashraf,Avinash Aujayeb,Anna Bibby,Rocco Bilancia,

    Introduction Pleural mesothelioma (PM) is often presaged by benign asbestos-associated pleural inflammation (AAPI), offering a unique window of opportunity for translational research. The PREDICT-Meso International Accelerator Network is leveraging this natural history to perform target identification and develop novel therapies for early-stage or pre-invasive disease. This requires assembly of a unique bioresource of longitudinal human tissue samples spanning the terminal stages of PM evolution, development of preclinical models for drug screening and reliable tools for risk prediction in patients presenting with AAPI.Methods and analysis Mesothelioma Observational study of Risk prediction and Generation of paired benign-meso tissue samples, Including a Nested MRI Substudy (Meso-ORIGINS) is a prospective, multicentre observational study, comprising two arms (A and B), with a nested MRI substudy in arm A. Arm A will recruit 300 AAPI patients and perform 6-monthly surveillance for 2 years. Suspicion of PM evolution will prompt repeat biopsy and banking, delivering a primary objective of ≥38 longitudinal AAPI-PM tissue pairs. This target reflects a projected PM evolution rate of 14% (95% CI 10.5 to 19.2) derived from a prior multicentre feasibility trial. Multiomic risk profiling will be performed in arm A, using blood proteomics, exhaled breath metabolomics and perfusion MRI. Arm B will recruit 300 patients with suspected PM, permitting collection of multiregion pleural biopsies in patients spanning AAPI and PM timepoints for evaluation of anatomical heterogeneity. Where possible, patients in arm B diagnosed with AAPI will be recruited to arm A for 2-year surveillance +/− repeat biopsy in subsequent PM evolution cases. Pleural fluid will be collected in arm B for cell-line generation and diagnostic biomarker evaluation. Exhaled breath will be collected in arm B for diagnostic biomarker evaluation.Ethics and dissemination The study has ethical approval (REC Ref 21/WS/0120). Results will be disseminated via peer-reviewed journals and national/international scientific conferences. Tissues, data and derived omics will be shared via the PREDICT-Meso Research Tissue Bank (REC Ref 21/WS/0011).Trial registration number ISRCTN22929761.

    2026BMJ open respiratory research(2026)
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 2475 篇论文

    合作机构(100)

    曼彻斯特大学合作论文 245
    曼彻斯特大学合作论文 93
    皇家帕普沃思医院合作论文 48
    牛津大学合作论文 29
    莱斯特大学合作论文 27
    帝国理工学院合作论文 24
    North Manchester General Hospital,Pennine Acute Hospitals NHS Trust合作论文 24
    皇家布朗普顿医院合作论文 23
    索尔福德皇家医院合作论文 23
    利物浦大学合作论文 23

    机构统计